MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/trc2.70157

Медицинская библиотека · Alzheimer's & dementia (New York, N. Y.) · 2025

Simulation of Alzheimer's diagnostic flows with blood biomarker test options in Japan.

Igarashi Ataru, Kimura Noriyuki, Ataka Takuya, Ito Temmei, Sasaki Kotaro, Kobayashi Chizuru, Tani Mayaka, Sakata Yukinori, Azuma Mie, Chida Ayano, Takeshima Tomomi, Iwasaki Kosuke, Matsubara Etsuro

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

This study projected the diagnostic testing landscape for lecanemab treatment in Japan under different workflows.

METHODS

A dynamic simulation estimated wait times and treatment-eligible patient numbers under four scenarios: current diagnostic workflow, blood biomarker (BBM) tests as triage tools, BBM tests for confirmatory diagnostics, and both combined. Willingness-to-pay (WTP) and intangible costs were assessed via an online survey to estimate testing demand.

RESULTS

The maximum mean wait time under the current workflow was projected at 6.4 months, decreasing with BBM integration. The number of treatment-eligible patients increased considerably with BBM-based confirmatory diagnostics. BBM triage testing reduced wait times but temporarily increased treatment-eligible patients.

DISCUSSION: Replacing positron emission tomography (PET) or cerebrospinal fluid with BBM-based diagnostics may increase treatment eligibility because of lower costs, driving higher demand for testing.

HIGHLIGHTS: A dynamic simulation models Alzheimer's diagnostic workflows in Japan.Blood biomarker (BBM) tests reduce diagnostic wait times for Alzheimer's in Japan.Implementing BBM tests improves access to Alzheimer's diagnostics.Study quantifies demand for diagnostic testing based on costs and accessibility.Testing costs impact the number of treatment-eligible Alzheimer's patients.

Для цитирования: Igarashi Ataru, Kimura Noriyuki, Ataka Takuya, Ito Temmei, Sasaki Kotaro, Kobayashi Chizuru, Tani Mayaka, Sakata Yukinori, Azuma Mie, Chida Ayano, Takeshima Tomomi, Iwasaki Kosuke, Matsubara Etsuro. Simulation of Alzheimer's diagnostic flows with blood biomarker test options in Japan.. Alzheimer's & dementia (New York, N. Y.). 2025. DOI: 10.1002/trc2.70157.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.